Fat Loss and Body Recomposition: SARMs aid in fat burning by increasing metabolic rate and preserving lean muscle during fat ...

Tuspetinib in combination with venetoclax and azacitidine (the TUS+VEN+AZA triplet) continues to demonstrate exciting antileukemic activity and safety across genetically diverse populations of newly ...

The Ratio Change is aimed to bring the price of the Company’s ADRs into compliance with the Nasdaq $1.00 minimum bid price per share requirement, although Biodexa can give no assurance that the Ratio ...

In addition to DuraPro™, Globus Medical launched Verzera™, a navigated high-speed drill system integrated with the ExcelsiusGPS and ExcelsiusHub system. Verzera™ augments existing workflows for ...

Event: Biotricity Fiscal 2025 Fourth Quarter Financial Results and Business Update Call Date: Friday, July 18, 2025 Time: 4:45 PM ET (1:45 PM PT) Toll Free: 1-877-269-7751 International: ...

Just Like Family Home Care, a trusted Canadian company, is proud to announce the launch of its services in Newmarket, Aurora, ...

Gain intends to use the net proceeds from the offering to continue clinical and nonclinical development of its lead product candidate GT-02287 for the treatment of neurodegenerative diseases, ...

KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for the ...

Combined Company to Trade on Nasdaq Under Ticker “IMA” Ikena Announces 1-for-12 Reverse Stock Split of Ikena Common Stock . BOSTON and SAN DIEGO, July 15, 2025 (GLOBE NEWSWIRE ...

Nixol introduces a new natural supplement in the United Kingdom to support metabolism, curb cravings, and promote healthy ...

Headquartered in New York, XLA Health provides outsourced front-office, billing and patient-engagement services exclusively to healthcare organizations. Its blended on-shore/near-shore workforce ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, ...